Crispr Therapeutics shares owned by Guggenheim Capital, LLC Managers
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Guggenheim Capital, LLC Managers
from 13F filings
Historical chart of Guggenheim Capital, LLC Managers investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Guggenheim Capital, LLC Managers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Guggenheim Capital, LLC Managers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $4.1M | 88k | 46.98 |
| 2024-06-30 | $2.9M | 53k | 54.01 |
| 2024-03-31 | $3.4M | 50k | 68.16 |
| 2023-12-31 | $2.2M | 36k | 62.60 |
| 2023-09-30 | $2.3M | 50k | 45.39 |
| 2023-06-30 | $3.9M | 70k | 56.14 |
| 2023-03-31 | $3.4M | 75k | 45.23 |
| 2022-12-31 | $3.3M | 82k | 40.65 |
| 2022-09-30 | $5.1M | 78k | 65.35 |
| 2022-06-30 | $4.5M | 74k | 60.75 |
| 2022-03-31 | $4.8M | 76k | 62.76 |
| 2021-12-31 | $6.5M | 86k | 75.79 |
| 2021-09-30 | $7.3M | 65k | 111.92 |
| 2021-06-30 | $5.1M | 32k | 162.31 |
| 2021-03-31 | $3.8M | 31k | 121.84 |
| 2020-12-31 | $2.9M | 19k | 153.10 |
More positions owned by Guggenheim Capital, LLC Managers
View all positions for Guggenheim Capital, LLC Managers